Past and prognosis of anti-VEGF therapy for wet age-related macular degeneration-the future has begun.

David S. Boyer, Jeffrey S. Heier, David M. Brown, Steven F. Francom, Tsontcho Ianchulev, Roman G. Rubio, A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology. ,vol. 116, pp. 1731- 1739 ,(2009) , 10.1016/J.OPHTHA.2009.05.024

Susan E. Quaggin, Turning a blind eye to anti-VEGF toxicities Journal of Clinical Investigation. ,vol. 122, pp. 3849- 3851 ,(2012) , 10.1172/JCI65509

David M. Brown, Carl D. Regillo, Anti-VEGF Agents in the Treatment of Neovascular Age-related Macular Degeneration: Applying Clinical Trial Results to the Treatment of Everyday Patients American Journal of Ophthalmology. ,vol. 144, pp. 627- 637.e2 ,(2007) , 10.1016/J.AJO.2007.06.039

Soraya Rofagha, Robert B Bhisitkul, David S Boyer, SriniVas R Sadda, Kang Zhang, Seven-Up Study Group, Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology. ,vol. 120, pp. 2292- 2299 ,(2013) , 10.1016/J.OPHTHA.2013.03.046

David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider, None, Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 355, pp. 1432- 1444 ,(2006) , 10.1056/NEJMOA062655

W M Amoaku, U Chakravarthy, R Gale, M Gavin, F Ghanchi, J Gibson, S Harding, R L Johnston, S Kelly, A Lotery, S Mahmood, G Menon, S Sivaprasad, J Talks, A Tufail, Y Yang, Defining response to anti-VEGF therapies in neovascular AMD Eye. ,vol. 29, pp. 721- 731 ,(2015) , 10.1038/EYE.2015.48

Ursula M Schmidt‐Erfurth, Gisbert Richard, Albert Augustin, William G Aylward, Francesco Bandello, Borja Corcostegui, José Cunha‐Vaz, Alain Gaudric, Anita Leys, Rainier O Schlingemann, European Society for Retina Specialists' Guidelines Committee (EURETINA), Guidance for the treatment of neovascular age‐related macular degeneration Acta Ophthalmologica Scandinavica. ,vol. 85, pp. 486- 494 ,(2007) , 10.1111/J.1600-0420.2007.00979.X

Lisa Ord, JoAnne Wright, Margaret DeAngelis, Michael Feehan, Quality of Life with Macular Degeneration Is Not as Dark as It May Seem: Patients' Perceptions of the MacDQoL Questionnaire. Journal of Clinical Medicine. ,vol. 4, pp. 1841- 1852 ,(2015) , 10.3390/JCM4091841

Michael Stewart, Individualized Treatment of Neovascular Age-Related Macular Degeneration: What are Patients Gaining? Or Losing? Journal of Clinical Medicine. ,vol. 4, pp. 1079- 1101 ,(2015) , 10.3390/JCM4051079

Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim, None, Ranibizumab for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 355, pp. 1419- 1431 ,(2006) , 10.1056/NEJMOA054481